Biogen Inc (BIIB)
208.98
+6.52
(+3.22%)
USD |
NASDAQ |
Apr 26, 16:00
209.50
+0.52
(+0.25%)
After-Hours: 18:07
Biogen Debt to Equity Ratio: 0.4299 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.4299 |
| December 31, 2023 | 0.4688 |
| September 30, 2023 | 0.5031 |
| June 30, 2023 | 0.4344 |
| March 31, 2023 | 0.4554 |
| December 31, 2022 | 0.4688 |
| September 30, 2022 | 0.4915 |
| June 30, 2022 | 0.6129 |
| March 31, 2022 | 0.6471 |
| December 31, 2021 | 0.6675 |
| September 30, 2021 | 0.6971 |
| June 30, 2021 | 0.6761 |
| March 31, 2021 | 0.6803 |
| December 31, 2020 | 0.694 |
| September 30, 2020 | 0.6902 |
| June 30, 2020 | 0.6565 |
| March 31, 2020 | 0.4752 |
| December 31, 2019 | 0.4463 |
| September 30, 2019 | 0.4254 |
| June 30, 2019 | 0.4592 |
| March 31, 2019 | 0.4297 |
| December 31, 2018 | 0.4553 |
| September 30, 2018 | 0.4308 |
| June 30, 2018 | 0.4835 |
| March 31, 2018 | 0.4221 |
| Date | Value |
|---|---|
| December 31, 2017 | 0.4708 |
| September 30, 2017 | 0.5063 |
| June 30, 2017 | 0.5623 |
| March 31, 2017 | 0.5675 |
| December 31, 2016 | 0.5368 |
| September 30, 2016 | 0.5393 |
| June 30, 2016 | 0.5738 |
| March 31, 2016 | 0.6334 |
| December 31, 2015 | 0.6963 |
| September 30, 2015 | 0.618 |
| June 30, 2015 | 0.0461 |
| March 31, 2015 | 0.0501 |
| December 31, 2014 | 0.054 |
| September 30, 2014 | 0.0563 |
| June 30, 2014 | 0.0617 |
| March 31, 2014 | 0.0651 |
| December 31, 2013 | 0.0691 |
| September 30, 2013 | 0.0859 |
| June 30, 2013 | 0.0923 |
| March 31, 2013 | 0.1247 |
| December 31, 2012 | 0.1639 |
| September 30, 2012 | 0.1669 |
| June 30, 2012 | 0.1746 |
| March 31, 2012 | 0.1712 |
| December 31, 2011 | 0.1656 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.4254
Minimum
Sep 2019
0.6971
Maximum
Sep 2021
0.554
Average
0.4973
Median
Debt to Equity Ratio Benchmarks
| Eli Lilly and Co | 2.342 |
| Bristol-Myers Squibb Co | 1.351 |
| Gilead Sciences Inc | 1.094 |
| AbbVie Inc | 5.732 |
| Regeneron Pharmaceuticals Inc | 0.0763 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 26.57B |
| Total Liabilities (Quarterly) | 11.35B |
| Shareholders Equity (Quarterly) | 15.21B |
| Current Ratio | 2.096 |
| Net Debt Paydown Yield | -0.17% |